DEX Combined With RTX, CSA and IVIG in the Management of Newly Diagnosed ITP Patients

This study was undertaken to report the efficacy and safety of dexamethasone combined with rituximab, cyclosporin and intravenous immunoglobulin in the management of newly diagnosed ITP patients. dexamethasone is an agonist of the glucocorticoid receptor the results in the reduction of immune response.

China

https://clinicaltrials.gov/ct2/show/NCT02834468?recrs=a&cond=ITP&draw=1&rank=9

UNKNOWN RECRUITING STATUS

back to top

BBB Cleveland logo GuideStar Seal NORD Member Badge 2018THSNA logo